Y2K Global Innovation LAB is a Korea-based consulting and business development firm specializing in corporate strategy, global tech transfer, M&A, and investment advisory in the pharma, biotech, and medtech sectors. Backed by a multidisciplinary team and recognized by the Korean government, Y2K GIL supports top life science companies through strategic partnerships and commercialization, including advisory roles for KIT’s DIPS 1000+ program.